Targeting cadherin-17 inactivates wnt signaling and inhibits tumor growth in liver carcinoma (Hepatology (2009) 50, DOI: 10.1002/hep.23143)

by Luk, J.M.
Published 2016

Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma

by Wong, K.-F., Luk, J.M.
Published 2014

Proteomics of hepatocellular carcinoma in chinese patients

by Luk, J.M., Liu, A.M.
Published 2014

An update on targeting Hippo-YAP signaling in liver cancer

by Liu, A.M., Xu, Z., Luk, J.M.
Published 2014

Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents

by Wong, K.-F., Yuan, Y., Luk, J.M.
Published 2016

Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: Pathogenesis and therapeutic implications

by Chan, K.L., Wong, K.F., Luk, J.M.
Published 2016

Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma

by Chung, Y., Law, S., Kwong, D.L.W., Luk, J.M.
Published 2016

Circulating markers for prognosis of hepatocellular carcinoma

by Wong, K.-F., Xu, Z., Chen, J., Lee, N.P., Luk, J.M.
Published 2014

Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma

by Wong, K.-F, Liu, A.M, Hong, W, Xu, Z, Luk, J.M
Published 2020

Regulators of mammalian Hippo pathway in cancer

by Liu, A.M., Wong, K.-F., Jiang, X., Qiao, Y., Luk, J.M.
Published 2014

Prophylactic uses of integrin CD18-βA peptide in a murine polymicrobial peritonitis model

by Wong, K.-F., Wo, J., Ho, D., Poon, R.T., Casasnovas, J.M., Luk, J.M.
Published 2014

Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma

by Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M.
Published 2016

A morpho-molecular prognostic model for hepatocellular carcinoma

by Srivastava, S, Wong, KF, Ong, CW, Chan, YH, Yeoh, KG, Teh, M, Luk, JM, Salto-Tellez, M
Published 2020

Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma

by Liu, A.M., Zhang, C., Burchard, J., Fan, S.T., Wong, K.-F., Dai, H., Poon, R.T., Luk, J.M.
Published 2014

Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression

by Li J., Lau G., Chen L., Yuan Y.-F., Huang J., Luk J.M., Xie D., Guan X.-Y.
Published 2020

Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma

by Huo, X., Zhang, Q., Liu, A.M., Tang, C., Gong, Y., Bian, J., Luk, J.M., Xu, Z., Chen, J.
Published 2014

MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

by Liu, A.M., Xu, Z., Shek, F.H., Wong, K.-F., Lee, N.P., Poon, R.T., Chen, J., Luk, J.M.
Published 2014

Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)

by Sun, S., Poon, R.T.P., Lee, N.P., Yeung, C., Chan, K.L., Ng, I.O.L., Day, P.J.R., Luk, J.M.
Published 2016

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study

by Liu, A.M., Yao, T.-J., Wang, W., Wong, K.-F., Lee, N.P., Fan, S.T., Poon, R.T.P., Gao, C., Luk, J.M.
Published 2014

Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma

by Luk, J.M., Su, Y.C.F., Lam, S.C.T., Lee, C.K., Hu, M.Y., He, Q.Y., Lau, G.K., Wong, F.W.S., Fan, S.-T.
Published 2014